We measured plasma intercellular adhesion molecule-1 (ICAM-1) and Angiopoietin-2 levels in 29 corticosteroid resistant ITP patients during their consecutive treatments of low-dose decitabine and assessed the predictive value of the two markers for treatment response. The gene discussed is ANGPT2; the disease is autoimmune thrombocytopenic purpura.